165 related articles for article (PubMed ID: 32788885)
1. Therapeutic inhibition of microRNA-21 (miR-21) using locked-nucleic acid (LNA)-anti-miR and its effects on the biological behaviors of melanoma cancer cells in preclinical studies.
Javanmard SH; Vaseghi G; Ghasemi A; Rafiee L; Ferns GA; Esfahani HN; Nedaeinia R
Cancer Cell Int; 2020; 20():384. PubMed ID: 32788885
[TBL] [Abstract][Full Text] [Related]
2. Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.
Nedaeinia R; Sharifi M; Avan A; Kazemi M; Rafiee L; Ghayour-Mobarhan M; Salehi R
Cancer Gene Ther; 2016 Aug; 23(8):246-53. PubMed ID: 27364574
[TBL] [Abstract][Full Text] [Related]
3. LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.
Najafi Z; Sharifi M; Javadi G
J Gastrointest Cancer; 2020 Mar; 51(1):109-115. PubMed ID: 30815771
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia.
Dehkordi KA; Chaleshtori MH; Sharifi M; Jalili A; Fathi F; Roshani D; Nikkhoo B; Hakhamaneshi MS; Sani MRM; Ganji-Arjenaki M
Indian J Hematol Blood Transfus; 2017 Sep; 33(3):327-332. PubMed ID: 28824233
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
[TBL] [Abstract][Full Text] [Related]
6. Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.
Sharifi M; Salehi R
Cancer Gene Ther; 2016 Jan; 23(1):29-35. PubMed ID: 26658357
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.
Di Martino MT; Gullà A; Gallo Cantafio ME; Altomare E; Amodio N; Leone E; Morelli E; Lio SG; Caracciolo D; Rossi M; Frandsen NM; Tagliaferri P; Tassone P
PLoS One; 2014; 9(2):e89659. PubMed ID: 24586944
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity of miR-92a-Locked Nucleic Acid (LNA)-Inhibitor against endometrial cancer.
Torres A; Kozak J; Korolczuk A; Wdowiak P; Domańska-Glonek E; Maciejewski R; Torres K
BMC Cancer; 2016 Oct; 16(1):822. PubMed ID: 27782822
[TBL] [Abstract][Full Text] [Related]
9. Antisense LNA-loaded nanoparticles of star-shaped glucose-core PCL-PEG copolymer for enhanced inhibition of oncomiR-214 and nucleolin-mediated therapy of cisplatin-resistant ovarian cancer cells.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Int J Pharm; 2020 Jan; 573():118729. PubMed ID: 31705975
[TBL] [Abstract][Full Text] [Related]
10. miR-20a inhibition using locked nucleic acid (LNA) technology and its effects on apoptosis of human macrophages infected by Toxoplasma gondii RH strain.
Rezaei F; Daryani A; Sharifi M; Sarvi S; Jafari N; Pagheh AS; Hashemi N; Hejazi SH
Microb Pathog; 2018 Aug; 121():269-276. PubMed ID: 29800695
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
12. Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo.
Torres A; Kozak J; Korolczuk A; Rycak D; Wdowiak P; Maciejewski R; Torres K
Oncotarget; 2016 Nov; 7(45):73651-73663. PubMed ID: 27655663
[TBL] [Abstract][Full Text] [Related]
13. miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.
Santolla MF; Lappano R; Cirillo F; Rigiracciolo DC; Sebastiani A; Abonante S; Tassone P; Tagliaferri P; Di Martino MT; Maggiolini M; Vivacqua A
J Exp Clin Cancer Res; 2018 May; 37(1):94. PubMed ID: 29716623
[TBL] [Abstract][Full Text] [Related]
14. LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration.
Luan J; Fu J; Chen C; Jiao C; Kong W; Zhang Y; Chang Q; Wang Y; Li D; Illei GG; Kopp JB; Pi J; Zhou H
Arthritis Res Ther; 2019 Dec; 21(1):276. PubMed ID: 31829247
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.
Hinkel R; Penzkofer D; Zühlke S; Fischer A; Husada W; Xu QF; Baloch E; van Rooij E; Zeiher AM; Kupatt C; Dimmeler S
Circulation; 2013 Sep; 128(10):1066-75. PubMed ID: 23897866
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA miR-92a induces apoptosis and necrosis in human acute promyelocytic leukemia.
Sharifi M; Salehi R; Gheisari Y; Kazemi M
Adv Biomed Res; 2014; 3():61. PubMed ID: 24627869
[TBL] [Abstract][Full Text] [Related]
18. Anticancer effects of miR-200c in colorectal cancer through BMI1.
Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R
J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction in acute promyelocytic leukemia cells through upregulation of
Sharifi M; Fasihi-Ramandi M; Sheikhi A; Moridnia A; Saneipour M
Mol Biol Res Commun; 2018 Mar; 7(1):25-33. PubMed ID: 29911120
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4.
Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R
Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]